418 related articles for article (PubMed ID: 33201019)
1. Planning for a Gonococcal Vaccine: A Narrative Review of Vaccine Development and Public Health Implications.
Abara WE; Jerse AE; Hariri S; Kirkcaldy RD
Sex Transm Dis; 2021 Jul; 48(7):453-457. PubMed ID: 33201019
[TBL] [Abstract][Full Text] [Related]
2. Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.
Marjuki H; Topaz N; Joseph SJ; Gernert KM; Kersh EN; ; Wang X
mBio; 2019 Sep; 10(5):. PubMed ID: 31506309
[TBL] [Abstract][Full Text] [Related]
3. An open-label randomised controlled trial evaluating the efficacy of a meningococcal serogroup B (4CMenB) vaccine on Neisseria gonorrhoeae infection in gay and bisexual men: the MenGO study protocol.
Thng C; Semchenko EA; Hughes I; O'Sullivan M; Seib KL
BMC Public Health; 2023 Mar; 23(1):607. PubMed ID: 36997957
[TBL] [Abstract][Full Text] [Related]
4. A Gonococcal Vaccine Has the Potential to Rapidly Reduce the Incidence of Neisseria gonorrhoeae Infection Among Urban Men Who Have Sex With Men.
Hui BB; Padeniya TN; Rebuli N; Gray RT; Wood JG; Donovan B; Duan Q; Guy R; Hocking JS; Lahra MM; Lewis DA; Whiley DM; Regan DG; Seib KL
J Infect Dis; 2022 Mar; 225(6):983-993. PubMed ID: 34894134
[TBL] [Abstract][Full Text] [Related]
5. VA-MENGOC-BC Vaccination Induces Serum and Mucosal Anti Neisseria gonorrhoeae Immune Responses and Reduces the Incidence of Gonorrhea.
Reyes Díaz LM; Lastre González MSJB; Cuello M; Sierra-González VG; Ramos Pupo R; Lantero MI; Harandi AM; Black S; Pérez O
Pediatr Infect Dis J; 2021 Apr; 40(4):375-381. PubMed ID: 33591079
[TBL] [Abstract][Full Text] [Related]
6. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
[TBL] [Abstract][Full Text] [Related]
7. Public health impact and cost-effectiveness of gonorrhoea vaccination: an integrated transmission-dynamic health-economic modelling analysis.
Whittles LK; Didelot X; White PJ
Lancet Infect Dis; 2022 Jul; 22(7):1030-1041. PubMed ID: 35427491
[TBL] [Abstract][Full Text] [Related]
8. Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019.
Gottlieb SL; Ndowa F; Hook EW; Deal C; Bachmann L; Abu-Raddad L; Chen XS; Jerse A; Low N; MacLennan CA; Petousis-Harris H; Seib KL; Unemo M; Vincent L; Giersing BK;
Vaccine; 2020 Jun; 38(28):4362-4373. PubMed ID: 32359875
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: a retrospective observational study.
Abara WE; Bernstein KT; Lewis FMT; Schillinger JA; Feemster K; Pathela P; Hariri S; Islam A; Eberhart M; Cheng I; Ternier A; Slutsker JS; Mbaeyi S; Madera R; Kirkcaldy RD
Lancet Infect Dis; 2022 Jul; 22(7):1021-1029. PubMed ID: 35427490
[TBL] [Abstract][Full Text] [Related]
10. The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae.
Leduc I; Connolly KL; Begum A; Underwood K; Darnell S; Shafer WM; Balthazar JT; Macintyre AN; Sempowski GD; Duncan JA; Little MB; Rahman N; Garges EC; Jerse AE
PLoS Pathog; 2020 Dec; 16(12):e1008602. PubMed ID: 33290434
[TBL] [Abstract][Full Text] [Related]
11. The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae.
Semchenko EA; Tan A; Borrow R; Seib KL
Clin Infect Dis; 2019 Sep; 69(7):1101-1111. PubMed ID: 30551148
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive observational study evaluating the enduring effectiveness of 4CMenB, the meningococcal B vaccine against gonococcal infections in the Northern Territory and South Australia, Australia: study protocol.
Marshall H; Ward J; Wang B; Andraweera P; McMillan M; Flood L; Bell C; Sisnowski J; Krause V; Webby R; Childs E; Gunathilake M; Egoroff N; Leong L; Lawrence A; Baird R; Freeman K; Menouhos D; Whiley DM; Karnon J; van Hal S; Lahra MM
BMJ Open; 2024 May; 14(5):e079144. PubMed ID: 38719318
[TBL] [Abstract][Full Text] [Related]
13. Neisseria gonorrhoeae vaccine development: hope on the horizon?
Edwards JL; Jennings MP; Seib KL
Curr Opin Infect Dis; 2018 Jun; 31(3):246-250. PubMed ID: 29601324
[TBL] [Abstract][Full Text] [Related]
14. The potential impact of vaccination on the prevalence of gonorrhea.
Craig AP; Gray RT; Edwards JL; Apicella MA; Jennings MP; Wilson DP; Seib KL
Vaccine; 2015 Aug; 33(36):4520-4525. PubMed ID: 26192351
[TBL] [Abstract][Full Text] [Related]
15. Promising developments in gonococcal vaccines.
Waltmann A; Chen JS; Duncan JA
Curr Opin Infect Dis; 2024 Feb; 37(1):63-69. PubMed ID: 38050729
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the Potential of Vaccination to Combat Antibiotic Resistance in Gonorrhea: A Modeling Analysis to Determine Preferred Product Characteristics.
Whittles LK; White PJ; Didelot X
Clin Infect Dis; 2020 Nov; 71(8):1912-1919. PubMed ID: 31905399
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial Susceptibility of Urogenital and Extragenital Neisseria gonorrhoeae Isolates Among Men Who Have Sex With Men: Strengthening the US Response to Resistant Gonorrhea and Enhanced Gonococcal Isolate Surveillance Project, 2018 to 2019.
Quilter LAS; St Cyr SB; Hong J; Asbel L; Bautista I; Carter B; Casimir Y; Denny M; Ervin M; Gomez R; Harvey A; Holderman JL; Johnson K; Kohn RP; Learner ER; Mauk K; Menza T; Mettenbrink C; Nettleton WD; Nicosia KR; Pham CD; Ried C; Schlanger K; Schneider A; Soge OO; Tabidze I; Taylor SN; Tilghman W; Toler C; Weinstock H; Torrone EA
Sex Transm Dis; 2021 Dec; 48(12S Suppl 2):S111-S117. PubMed ID: 34475363
[TBL] [Abstract][Full Text] [Related]
18. Gonococcal Vaccines for Controlling Neisseria gonorrhoeae in Men Who Have Sex With Men: A Promising Game Changer.
Christensen H; Vickerman P
J Infect Dis; 2022 Mar; 225(6):931-933. PubMed ID: 34894131
[No Abstract] [Full Text] [Related]
19. Association between STI screening intensity in men who have sex with men and gonococcal susceptibility in 21 States in the USA: an ecological study.
Van Dijck C; Laumen J; Zlotorzynska M; Manoharan-Basil SS; Kenyon C
Sex Transm Infect; 2020 Nov; 96(7):537-540. PubMed ID: 32066589
[TBL] [Abstract][Full Text] [Related]
20. Immune responses to
Belcher T; Rollier CS; Dold C; Ross JDC; MacLennan CA
Front Immunol; 2023; 14():1248613. PubMed ID: 37662926
[No Abstract] [Full Text] [Related]
[Next] [New Search]
